Article thumbnail

Expression and Activity of a Novel Cathelicidin from Domestic Cats

By Brian C. Leonard, Hiutung Chu, Jennifer L. Johns, Richard L. Gallo, Peter F. Moore, Stanley L. Marks and Charles L. Bevins


Cathelicidins are small cationic antimicrobial peptides found in many species including primates, mammals, marsupials, birds and even more primitive vertebrates, such as the hagfish. Some animals encode multiple cathelicidins in their genome, whereas others have only one. This report identifies and characterizes feline cathelicidin (feCath) as the sole cathelicidin in domestic cats (Felis catus). Expression of feCath is predominantly found in the bone marrow, with lower levels of expression in the gastrointestinal tract and skin. By immunocytochemistry, feCath localizes to the cytoplasm of neutrophils in feline peripheral blood. Structurally, the mature feCath sequence is most similar to a subgroup of cathelicidins that form linear α-helices. feCath possesses antimicrobial activity against E. coli D31, Salmonella enterica serovar Typhimurium (IR715), Listeria monocytogenes and Staphylococcus pseudintermedius (clinical isolate) similar to that of the human ortholog, LL-37. In contrast, feCath lacks the DNA binding activity seen with LL-37. Given its similarity in sequence, structure, tissue expression, and antimicrobial activity, the cathelicidin encoded by cats, feCath, belongs to the subgroup of linear cathelicidins found not only in humans, but also non-human primates, dogs, mice, and rats

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
  2. (1991). Amino acidsequence ofPR-39. Isolation frompigintestineof anew memberofthefamily of proline-arginine-rich antibacterial peptides.
  3. (2003). Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
  4. (1997). Antimicrobial Peptide Protocols;
  5. (2002). Antimicrobial peptides of multicellular organisms.
  6. (2007). Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.
  7. (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.
  8. (1993). Chemotactic and protease-inhibiting activities of antibiotic peptide precursors.
  9. (2006). Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli.
  10. (2006). Development and evaluation of canine reference genes for accurate quantification of gene expression.
  11. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
  12. (2006). Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.
  13. (1995). FALL39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.
  14. (2005). Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.
  15. (1997). Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.
  16. (2007). Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
  17. (1990). Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins.
  18. Johnsen AH,Borregaard N(1995) hCAP-18,a cathelin/pro-bactenecinlike protein of human neutrophil specific granules.
  19. (2000). LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
  20. (1998). Localization and genomic organization of sheep antimicrobial peptide genes.
  21. (2006). Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.
  22. (2003). Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides.
  23. (2007). Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.
  24. (2004). Primate defensins.
  25. (2000). Structural features and biological activities of the cathelicidin-derived antimicrobial peptides.
  26. (1988). Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils.
  27. (1993). The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics.
  28. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders.
  29. (2000). The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.
  30. (1999). The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6.
  31. (2005). The role of cathelicidins in the innate host defenses of mammals.
  32. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
  33. (1991). Ultrasensitive assays for endogenous antimicrobial polypeptides.
  34. (2006). Using circular dichroism spectra to estimate protein secondary structure.